Meghan Rivera, US President, Organon

Meghan Rivera is an accomplished healthcare executive with over 20 years of experience driving growth, transformation, and commercial innovation across biopharma, medical device, and digital therapeutics. Most recently she served as U.S. President at Organon where she oversaw the full commercial organization, leading teams to record-setting growth, reimagining go-to-market strategy, and building high-performing cultures grounded in accountability and performance.

A passionate brand strategist at heart, Meghan has led marketing and commercial teams behind some of the life sciences industry's most innovative and award-winning campaigns. Her expertise spans brand building, customer engagement, omnichannel strategy, and launch excellence—consistently unlocking market-shaping impact and elevating creative standards in healthcare.

Her broader leadership experience includes general management, large-scale P&L ownership, go-to-market innovation, digital transformation, and investor relations. She has played key roles in delivering double-digit topline growth, leading one of the largest Series D raises in digital therapeutics, and integrating medtech and pharma models in complex organizations.

A recognized industry voice, Meghan is a frequent speaker, panelist, and advisor across leading industry forums. She serves as a seasoned judge for marketing and healthcare awards including MM+M, 4A’s, and the Effies, and has been featured in national publications including USA Today and The Washington Post.